The minimal concentration of the N-terminal 61 amino acid region of CLSP, CLSP(1-61), that is required to inhibit AD-related neuronal cell death completely was about 0.5 nM, which is equivalent to that of wt CLSP (Supplementary Fig. 15). This evidence concerns the gene CALML5 and Alzheimer disease.